Market Closed -
Nyse
04:01:50 2024-05-08 pm EDT
5-day change
1st Jan Change
12.42
USD
+1.39%
+4.99%
-36.05%
Nu Skin Enterprises : Balance Sheet
November 01, 2023 at 04:40 pm EDT
Nu Skin Enterprises, Inc.
Balance Sheet Data
Q3 2021 to Q3 2023
In thousands of US$
Q3
Q4
Q1
Q2
Q3
Q4
Q1
Q2
Q3
ASSETS
2021
2021
2022
2022
2022
2022
2023
2023
2023
Current assets
Cash & cash equivalents
282,412.0
339,593.0
302,216.0
363,923.0
294,136.0
264,725.0
229,941.0
235,554.0
233,314.0
Current investments
19,190.0
15,221.0
15,313.0
17,877.0
13,868.0
13,784.0
16,774.0
16,772.0
16,673.0
Accounts receivable
52,441.0
41,299.0
52,171.0
43,694.0
47,991.0
47,360.0
60,008.0
67,166.0
77,251.0
Inventory
415,203.0
399,931.0
381,585.0
354,211.0
327,481.0
346,183.0
366,537.0
372,250.0
291,103.0
Other current assets
121,626.0
76,906.0
97,923.0
103,188.0
94,366.0
87,816.0
100,302.0
100,833.0
82,781.0
Total current assets
890,872.0
872,950.0
849,208.0
882,893.0
777,842.0
759,868.0
773,562.0
792,575.0
701,122.0
Fixed Assets (net)
464,049.0
453,674.0
448,822.0
443,036.0
433,367.0
444,806.0
437,986.0
430,328.0
428,932.0
Right of Use Assets (net)
128,887.0
120,973.0
132,949.0
118,413.0
105,103.0
98,734.0
98,683.0
94,707.0
86,315.0
Goodwill & other intangible assets
304,079.0
283,423.0
281,306.0
279,097.0
275,175.0
273,133.0
271,143.0
342,088.0
338,441.0
Other assets (long term)
186,522.0
175,460.0
179,964.0
177,462.0
171,685.0
244,429.0
243,271.0
234,078.0
238,281.0
Total assets
1,974,409.0
1,906,480.0
1,892,249.0
1,900,901.0
1,763,172.0
1,820,970.0
1,824,645.0
1,893,776.0
1,793,091.0
LIABILITIES AND STOCKHOLDER'S EQUITY
Current liabilities
Accounts payable
52,023.0
49,993.0
40,719.0
55,013.0
41,620.0
53,963.0
49,494.0
49,529.0
48,583.0
Accrued expenses
378,573.0
372,201.0
343,737.0
289,130.0
281,418.0
280,280.0
275,774.0
255,510.0
245,432.0
Current portion of long-term debt
110,000.0
107,500.0
110,000.0
40,000.0
42,500.0
25,000.0
47,500.0
140,000.0
140,000.0
Total current liabilities
540,596.0
529,694.0
494,456.0
384,143.0
365,538.0
359,243.0
372,768.0
445,039.0
434,015.0
Lease Liability
95,741.0
88,759.0
100,844.0
90,156.0
78,053.0
76,540.0
78,776.0
74,487.0
68,208.0
Long-term debt
278,563.0
268,781.0
258,995.0
387,179.0
382,323.0
377,466.0
372,609.0
367,753.0
362,896.0
Other liabilities
123,032.0
106,474.0
103,754.0
98,388.0
95,324.0
110,425.0
107,522.0
111,152.0
105,785.0
Total liabilities
1,037,932.0
993,708.0
958,049.0
959,866.0
921,238.0
923,674.0
931,675.0
998,431.0
970,904.0
Stockholder's equity
Capital Stock
91.0
91.0
91.0
91.0
91.0
91.0
91.0
91.0
91.0
Additional paid-in capital
590,678.0
601,703.0
599,258.0
606,349.0
609,886.0
613,278.0
611,483.0
615,579.0
619,193.0
Treasury stock, at cost
(1,518,535.0)
(1,526,860.0)
(1,526,778.0)
(1,520,769.0)
(1,559,967.0)
(1,569,061.0)
(1,559,080.0)
(1,557,777.0)
(1,570,718.0)
Other comprehensive income / (loss)
(75,658.0)
(73,896.0)
(69,528.0)
(90,638.0)
(109,385.0)
(86,509.0)
(91,005.0)
(101,446.0)
(108,836.0)
Retained earnings
1,939,901.0
1,911,734.0
1,931,157.0
1,946,002.0
1,901,309.0
1,939,497.0
1,931,481.0
1,938,898.0
1,882,457.0
Total stockholder's equity
936,477.0
912,772.0
934,200.0
941,035.0
841,934.0
897,296.0
892,970.0
895,345.0
822,187.0
Total liabilities & equity
1,974,409.0
1,906,480.0
1,892,249.0
1,900,901.0
1,763,172.0
1,820,970.0
1,824,645.0
1,893,776.0
1,793,091.0
Attachments
Original Link
Original Document
Permalink
Disclaimer
Nu Skin Enterprises Inc. published this content on 01 November 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 01 November 2023 20:38:42 UTC .
Transcript : Nu Skin Enterprises, Inc., Q1 2024 Earnings Call, May 08, 2024
May. 08
(NUS) NU SKIN ENTERPRISES Expects Q2 EPS Range $0.10 - $0.20
May. 08
MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q1 Revenue $417.3M, vs. Street Est of $432.4M
May. 08
MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q1 EPS $0.09, vs. Street Est of $0.05
May. 08
MT
Nu Skin Enterprises, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 08
CI
Nu Skin Enterprises, Inc. Announces Quarterly Dividend, Payable on June 12, 2024
May. 08
CI
Nu Skin Enterprises, Inc. Announces Retirement of Andrew Lipman as Board of Directors
Mar. 18
CI
Sector Update: Consumer Stocks Advance Premarket Thursday
Feb. 15
MT
US Equity Futures Remain Little Changed Pre-Bell as Weekly Jobless Claims Drop
Feb. 15
MT
Top Premarket Decliners
Feb. 15
MT
Nu Skin Enterprises' Q4 Adjusted Earnings, Revenue Decline; Quarterly Dividend Cut -- Shares Slump Pre-Bell
Feb. 15
MT
Transcript : Nu Skin Enterprises, Inc., Q4 2023 Earnings Call, Feb 14, 2024
Feb. 14
Tranche Update on Nu Skin Enterprises, Inc.'s Equity Buyback Plan announced on August 3, 2018.
Feb. 14
CI
Earnings Flash (NUS) NU SKIN ENTERPRISES Reports Q4 Revenue $488.6M, vs. Street Est of $476.4M
Feb. 14
MT
Earnings Flash (NUS) NU SKIN ENTERPRISES Posts Q4 EPS $0.37, vs. Street Est of $0.28
Feb. 14
MT
Nu Skin Enterprises, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024
Feb. 14
CI
Nu Skin Enterprises, Inc. Declares Quarterly Cash Dividend, Payable on March 6, 2024
Feb. 14
CI
Nu Skin Enterprises, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 14
CI
Nu Skin Enterprises, Inc. Approves and Adopts the Fifth Amended and Restated Bylaws
Feb. 06
CI
Transcript : Nu Skin Enterprises, Inc. Presents at 26th Annual ICR Conference, Jan-08-2024 through Jan-10-2024
Jan. 09
Nu Skin Opens New Production Facility in Shanghai
Nov. 29
MT
Nu Skin Enterprises, Inc. Opens New Manufacturing Facility in Shanghai, China
Nov. 29
CI
Nu Skin Enterprises Insider Sold Shares Worth $272,272, According to a Recent SEC Filing
Nov. 06
MT
Nu Skin Enterprises, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 02
CI
Transcript : Nu Skin Enterprises, Inc., Q3 2023 Earnings Call, Nov 01, 2023
Nov. 01
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Nu Skin Enterprises, Inc. is an integrated beauty and wellness company. The Company develops and distributes a comprehensive line of beauty and wellness solutions in approximately 50 markets worldwide. The Company has three brands, Nu Skin, a beauty brand; Pharmanex, a wellness brand; and ageLOC, an anti-aging brand. It develops and distributes products in two categories, beauty products and wellness products. The Company operates through seven segments: Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau; and Europe, Middle East and Africa, which includes markets in Europe, as well as Israel and South Africa. The Companyâs Rhyz strategic investment arm also includes two additional segments: Manufacturing and Rhyz other.
More about the company
Last Close Price
12.42
USD
Average target price
14.5
USD
Spread / Average Target
+16.75%
Consensus
1st Jan change
Capi.
-36.05% 608M +12.65% 391B +11.29% 132B +17.26% 77.19B -12.67% 67B -11.43% 46.43B -5.02% 38.45B +6.37% 34.77B +11.04% 18.02B +17.40% 16.21B
Other Personal Products
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1